Conexeu Sciences Inc. CNXU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.05M | 2.28M | 1.64M | 1.82M | 1.12M |
| Depreciation & Amortization | 5.40K | 11.40K | 6.40K | 6.60K | 6.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.32M | 2.36M | 1.71M | 1.90M | 1.26M |
| Operating Income | -7.32M | -2.36M | -1.71M | -1.90M | -1.26M |
| Income Before Tax | -7.73M | -2.30M | -1.72M | -1.88M | -1.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.73M | -2.30M | -1.72M | -1.88M | -1.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.73M | -2.30M | -1.72M | -1.88M | -1.30M |
| EBIT | -7.32M | -2.36M | -1.71M | -1.90M | -1.26M |
| EBITDA | -7.32M | -2.35M | -1.71M | -1.90M | -1.25M |
| EPS Basic | -0.29 | -0.11 | -0.09 | -0.10 | -0.09 |
| Normalized Basic EPS | -0.18 | -0.07 | -0.05 | -0.06 | -0.06 |
| EPS Diluted | -0.29 | -0.11 | -0.09 | -0.10 | -0.09 |
| Normalized Diluted EPS | -0.18 | -0.07 | -0.05 | -0.06 | -0.06 |
| Average Basic Shares Outstanding | 26.97M | 20.57M | 20.08M | 18.25M | 14.10M |
| Average Diluted Shares Outstanding | 26.97M | 20.57M | 20.08M | 18.25M | 14.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |